The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival
Open Access
- 2 September 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 21 (5), 573-577
- https://doi.org/10.1093/eurpub/ckq120
Abstract
Background: The complement of the cancer mortality to incidence ratio [1 – (M/I)] has been suggested as a valid proxy for 5-year relative survival. Whether this suggestion holds true for all types of cancer has not yet been adequately evaluated. Methods: We used publicly available databases of cancer incidence, cancer mortality and relative survival to correlate relative survival estimates and 1 – (M/I) estimates from Denmark, Finland, Iceland, Norway, Sweden, the USA and the Netherlands. We visually examined for which tumour sites 5-year relative survival cannot simply be predicted by the 1 – (M/I) and evaluated similarities between countries. Results: Country-specific linear regression analyses show that there is no systematic bias in predicting 5-year relative survival by 1 – (M/I) in five countries. There is a small but significant systematic underestimation of survival from prognostically poor tumour sites in two countries. Furthermore, the 1 – (M/I) overestimates survival from oral cavity and liver cancer with >10% in at least two of the seven countries. By contrast, the proxy underestimates survival from soft tissue, bone, breast, prostate and oesophageal cancer, multiple myeloma and leukaemia with >10% in at least two of the seven countries. Conclusion: The 1 – (M/I) is a good approximation of the 5-year relative survival for most but not all tumour sites.This publication has 9 references indexed in Scilit:
- Mapping cancer mortality‐to‐incidence ratios to illustrate racial and sex disparities in a high‐risk populationCancer, 2009
- EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentaryEuropean Journal of Cancer, 2009
- Evaluation of data quality in the cancer registry: Principles and methods Part II. CompletenessEuropean Journal of Cancer, 2009
- Prognosis for long-term survivors of cancerAnnals of Oncology, 2007
- Interpreting international comparisons of cancer survival: The effects of incomplete registration and the presence of death certificate only cases on survival estimatesEuropean Journal of Cancer, 2007
- The rising burden of cancer in the developing worldAnnals of Oncology, 2006
- Population-based monitoring of cancer patient survival in situations with imperfect completeness of cancer registrationBritish Journal of Cancer, 2005
- Excess mortality from breast cancer 20 years after diagnosis when life expectancy is normalBritish Journal of Cancer, 2001
- Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burdenInternational Journal of Cancer, 1993